According to Dr. Raman Gangakhedkar, a former scientist at the Indian Council of Medical Research (ICMR), relatively few people may be at danger from the COVID-19 vaccine, also known as Covishield.

Concerns over the uncommon adverse effects of the COVID-19 vaccine prompted Gangakhedkar to make the comment on Wednesday while chatting with News18.

According to Gangakhedkar, News18, just seven to eight people out of ten lakh recipients of the Covishield vaccine are at danger of developing Thrombosis Thrombocytopenia Syndrome (TTS), a rare adverse effect.

“The risk is highest when you get the first dose. It lowers with the second dose and is lowest with the third," News18 quoted the epidemiologist, as saying.

The scientist added that any negative effects would probably show up in the first two to three months. He continued by saying that the related risk is negligible considering the benefits of this vaccine for millions of patients.

The COVID-19 vaccination may have a rare adverse effect called Thrombosis with Thrombocytopenia Syndrome (TTS), according to recent admissions made in UK court documents by AstraZeneca, the pharmaceutical behemoth that developed the vaccine in collaboration with the University of Oxford.

A class action lawsuit in the UK notwithstanding, the corporation reiterated its commitment to patient safety.

The hallmark of TTS is low platelet counts (thrombocytopenia), which is insufficient for blood clotting, together with blood clots (thrombosis).

The largest vaccine manufacturer in the world, Serum Institute of India (SII), created the vaccine in India.

“Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines," AstraZeneca spokesperson said in a statement.

Amid the controversy, the Samajwadi Party claimed that the BJP received a "commission" from the COVID-19 vaccine's maker.

The RJD also claimed that the Center had given the nation's citizens the "wrong" vaccine.

Saurabh Bharadwaj, the minister of health in Delhi, added that the Center needs to start working quickly to address the reported negative effects.

you might also be interested in - AstraZeneca admits rare side effects of its Covishield vaccine